Measurement of the nuchal translucency = NT screening
The most often and best known chromosome disorder is Trisomy 21 (Down syndrome). Although the average age of a mother of a child with Down syndrome is elevated, time and again there are pregnant women of a younger age whose children have this chromosome condition.
It is the target of the NT screening to discover an early and individual assessment of the likelihood of the occurrence of the Down syndrome. To this end, a special ultrasound screening of the neck of the foetus is carried out in the 12 to 14th week of pregnancy and is intensively scrutinised.
In combination with a blood analysis of the mother, the likelihood of the occurrence of Trisomy 21 can be individually determined.
An NT Care
examination is of no risk to the child. It can serve as a decision basis for or against further diagnostics (amniocentesis). The reliability of the test’s result is around 95%.